Фармакотерапевтическая эффективность достижения контроля бронхиальной астмы у больных с холодовой бронхиальной гиперреактивностью в контрастные сезоны года

Колосов Виктор Павлович, Пирогов Алексей Борисович, Ю О Семиреч et al. · Bulletin physiology and pathology of respiration · 2010

The aim of the research is to verify the efficiency of different strategies of combined therapy and monotherapy by inhalation glucocorticosteroids (iGCS) in 105 patients with persistent bronchial asthma (BA) with cold bronchial hyperresponsiveness (cBHR) in winter and summer seasons of the year. The increasing volume of the combined therapy provides the probability of control achievement in BA patients with cBHR in 75,5% in winter and 84,4% in summer. The positive effect of monotherapy by iGCS on the clinical course of BA with cBHR was achieved in 53,5% and 56,7% of patients respectively to seasons of the year. The application of the combined medication budesonide/formoterol is optimal for the basis anti-inflammatory therapy in BA patients with cBHR.

Cited by 0 works.

Authors